作者
Ghanbar Mahmoodi Chalbatani, Hassan Dana, Feridon Memari, Elahe Gharagozlou, Shirin Ashjaei, Peyman Kheirandish Zarandi, Vahid Marmari, Habibollah Mahmoudzadeh, Ali Reza Maleki, Ehsan Sadeghian, Elham Zainali Nia, Seyed Rohollah Miri, Neda zainali Nia, Omid Rezaeian, Anahita Eskandary, Narges Razavi, Mohammad Shirkhoda, Fatemeh Nouri Rouzbahani
发表日期
2018/12/7
来源
Practical Laboratory Medicine
页码范围
e00113
出版商
Elsevier
简介
Cancer is the second leading cause of death globally. piRNAs, which are a novel type of identified small noncoding RNA (ncRNA), play a crucial role in cancer genomics. In recent years, a relatively large number of studies have demonstrated that several piRNA are aberrantly expressed in various kinds of cancers including gastric cancer, bladder cancer, breast cancer, colorectal cancer and Lung cancer and may probably serve as a novel therapeutic target and biomarker for cancer treatment. The present review summarized current advances in our knowledge of the roles of piRNAs in cancer.
学术搜索中的文章
GM Chalbatani, H Dana, F Memari, E Gharagozlou… - Practical laboratory medicine, 2019